MGF Injection, also known as Mechano Growth Factor, is a unique peptide within the insulin-like growth factor family. As a selective splice variant of insulin-like growth factor-1 (IGF-1), it possesses distinct and well-defined fundamental chemical properties that form the core basis for its subsequent physiological functions. From a chemical composition perspective, it is a small molecular peptide. Its mature molecular structure consists of 40 amino acids arranged in a specific sequence, with a clearly defined molecular composition and molecular weight. The molecular formula is C₁₂₄H₂₀₄N₄₂O₄₁S₁, and the molecular weight is approximately 2971.99 g/mol. Its most recognizable chemical feature is a unique terminal structure (E domain), which distinguishes it from other similar growth factors and endows it with specific physiological activity and functional specificity.
Our product
MGF COA
 |
||
| Certificate of Analysis | ||
| Compound name | MGF | |
| Grade | Pharmaceutical grade | |
| CAS No. | 12020-86-9 | |
| Quantity | 30g | |
| Packaging standard | PE bag+Al foil bag | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 20250109009 | |
| MFG | Jan 9th 2025 | |
| EXP | Jan 8th 2028 | |
| Structure |  |
|
| Item | Enterprise standard | Analysis result |
| Appearance | White or almost white powder | Conformed |
| Water content | ≤5.0% | 0.54% |
| Loss on drying | ≤1.0% | 0.42% |
| Heavy Metals | Pb≤0.5ppm | N.D. |
| As≤0.5ppm | N.D. | |
| Hg≤0.5ppm | N.D. | |
| Cd≤0.5ppm | N.D. | |
| Purity (HPLC) | ≥99.0% | 99.90% |
| Single impurity | <0.8% | 0.52% |
| Total microbial count | ≤750cfu/g | 95 |
| E. Coli | ≤2MPN/g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (by GC) | ≤5000ppm | 500ppm |
| Storage | Store in a sealed, dark, and dry place below -20°C | |
|
|
||
Rapid repair of muscle injury
MGF injection(Mechano Growth Factor), as an alternative splicing variant of insulin-like growth factor-1 (IGF-1), has the core advantages of strong local targeting, dual function of repair and growth, and activation of dormant/aging satellite cells. Unlike the standard systemic mode of action of IGF-1, its unique C-terminal E domain plays an irreplaceable regulatory role in the flesh system.
When flesh undergoes micro-damage due to exercise (resistance training, endurance sports), trauma (tears, contusions), or overloading, local inflammatory signals are released. This dual stimulation from mechanical stress and the inflammatory microenvironment activates the alternative splicing mechanism of the IGF-1 gene in flesh tissue, preferentially expressing the drug isoform containing the unique E domain (IGF-1Ec in humans).
Advantage of it:
The expression of MGF is highly localized and time-sensitive. It is rapidly upregulated only in damaged muscle regions, with detectable increases in mRNA and protein levels within hours after injury, peaking at 24–48 hours. Unlike standard IGF-1, which is primarily secreted by the liver and acts systemically via circulation, it does not require secretion from distant organs. This enables an **"immediate response at the injury site,"** offering faster and more targeted action compared to the slower, less precise response of systemic IGF-1, which cannot achieve the **"damage-and-repair"** precision of it.
Independent Signaling, Repair-Anti-Inflammatory
It initiates signal transduction by binding to IGF-1 receptors (IGF-1R) on flesh cells. Its unique E domain also enables independent activation of local pathways not reliant on IGF-1R, primarily through two key synergistic pathways:
- PI3K/Akt Pathway: Inhibits pro-apoptotic proteins to reduce secondary death of damaged flesh cells while activating the mTOR synthesis pathway to provide the metabolic foundation for repair.
- MAPK Pathway: Regulates the expression of genes related to cell proliferation and modulates the appropriate release of inflammatory factors to prevent excessive inflammation from exacerbating damage.
Advantage of MGF injection:
The unique E domain is critical for its independent biological functions, allowing it to act on flesh tissue independently of other parts of IGF-1 without relying on systemic hormonal regulation. This autonomy enables a **"repair-anti-inflammatory" balance**, avoiding side effects such as inflammatory dysregulation or abnormal cell proliferation that may arise from the systemic action of standard IGF-1.
Cellular Level: Comprehensive Regulation of Satellite Cells
The core of flesh repair lies in the mobilization of flesh satellite cells (quiescent myogenic stem cells). This is one of the most critical "activators" of satellite cells, comprehensively regulating their entire lifecycle:
- Activates quiescent satellite cells, transforming them into activated myoblasts.
- Drives rapid proliferation of myoblasts to form an adequate cell reserve.
- Promotes differentiation of myoblasts and their fusion with damaged flesh fibers to fill injury gaps.
- Facilitates orderly synthesis of the extracellular matrix to reconstruct the mechanical structure of flesh.
Advantage of Mechano Growth Factor:
Compared to other growth factors (such as growth hormone or standard IGF-1), it exhibits high specificity in activating satellite cells, targeting only those in damaged areas without affecting normal flesh tissue. This results in higher repair efficiency and significantly shortens recovery time: while natural repair of exercise-induced micro-damage typically takes 3–7 days, this intervention can reduce this to 2–4 days, while also minimizing the risk of secondary injury and flesh adhesion.
Reversing Aging and Dual Intervention with Broad Applicability
Muscle loss (sarcopenia) is categorized into age-related physiological decline and disuse-induced pathological atrophy. The core pathology involves "declining satellite cell function and anabolic-catabolic imbalance." The advantage of this lies in its ability to reverse this core pathological process. Furthermore, its applicability spans both types of sarcopenia, distinguishing it from other factors that may only address a single type. This positions MGF as a significant potential target for combating age-related flesh decline.
Age-Related Sarcopenia: In individuals over 60, satellite cells enter a senescent state, characterized by reduced proliferation and differentiation capacity. Concurrently, levels of anabolic hormones decline. This leads to an annual flesh mass loss of 1%-2%.
Disuse-Induced Muscle Atrophy:During prolonged bed rest, immobilization, or lack of physical activity, the absence of mechanical loading on flesh suppresses satellite cell activity. Simultaneously, protein degradation pathways become overly activated. This results in a significant decline in both flesh mass and strength within a short period.
Intervention mechanism of Mechano Growth Factor
(1) Reactivating Senescent/Dormant Satellite Cells and Maintaining Stem Cell Pool Activity
It can directly act on senescent satellite cells, downregulating senescence markers and restoring their activation capacity. It activates telomerase activity, delays telomere shortening, and extends proliferative lifespan. Additionally, it improves the microenvironment of satellite cells, providing optimal conditions for their activation and proliferation.
Advantage of MGF:
Most growth factors (such as standard IGF-1 or growth hormone) primarily act on young satellite cells and are unable to reactivate senescent or dormant ones. This limits their effectiveness in ameliorating age-related sarcopenia. In contrast, this can overcome the limitations imposed by age and disuse. Even under conditions of aging or prolonged immobilization, it can initiate the repair program of satellite cells, fundamentally preventing the progressive atrophy of flesh fibers.
(2) Reversing the Synthesis-Degradation Imbalance to Reduce Muscle Protein Loss
Addressing Age-Related Anabolic Deficiency: Independently of systemic hormones, it locally activates the mTOR pathway, compensating for the synthetic deficits caused by declining levels of growth hormone and testosterone.
Countering Disuse-Induced Excessive Catabolism: This potently inhibits the expression of degrading enzymes, blocks the overactivation of the ubiquitin-proteasome pathway, and reduces abnormal breakdown of flesh fibers.
Advantage of Mechano Growth Factor:
It does not rely on systemic hormone supplementation. It achieves a dual balance of "enhancing synthesis and inhibiting degradation" locally, avoiding side effects such as endocrine disruption associated with hormone replacement therapy. This broader mechanism makes it applicable to a wider population, including the elderly and individuals with hormonal imbalances.
(3)Improvement effect: Delaying flesh loss and maintaining muscle function
- For age-related sarcopenia: Long term it intervention can reduce the rate of flesh mass loss in elderly mice by more than 50%, increase flesh grip strength and endurance by about 30%, and delay the progression of sarcopenia;
- For disuse flesh atrophy: it can reduce the degree of flesh fiber atrophy by 40% -50%, shorten the recovery time of flesh function after disuse, and avoid irreversible muscle damage;
- Function maintenance: Improve the function of the neuromuscular junction, enhance the efficiency of flesh nerve innervation, reduce muscle weakness, bradykinesia and other obstacles, and improve the body's activity ability.
Muscle Hypertrophy and Strength Enhancement
MGF is not merely a "repair factor" but a core regulatory peptide for structural flesh growth and functional enhancement. Its advantage lies in "fundamentally supplementing myonuclei and bidirectionally regulating metabolism,"distinguishing it from other growth factors that are limited to short-term protein synthesis promotion. This enables it to achieve sustained hypertrophy and strength gains in flesh fibers.
Muscle fibers are multinucleated cells, and their growth capacity is directly related to the number of myonuclei-each nucleus can only regulate a specific cytoplasmic domain. An insufficient number of myonuclei limits the expansion of flesh fiber volume. Through the regulation of satellite cells, MGF directly increases the myonuclear count within flesh fibers, expanding the "genetic regulatory scope" of individual fibers and providing abundant transcriptional templates for contractile protein synthesis.
This is a key advantage distinguishing Mechano Growth Factor from standard IGF-1 and other growth factors. Standard IGF-1 primarily promotes protein synthesis and struggles to increase myonuclear numbers, leading only to short-term fluctuations in anabolism without overcoming the "nuclear limitation"of flesh fiber growth. In contrast, MGF's "myonuclear supplementation"** effect drives persistent flesh fiber hypertrophy rather than temporary volume fluctuations. Furthermore, the hypertrophic effect is long-lasting, with no significant regression shortly after discontinuation.
MGF Bidirectionally Regulates Protein Metabolism to Drive Muscle Fiber Volume Expansion
The essence of flesh hypertrophy is net growth resulting from a protein synthesis rate exceeding the degradation rate. MGF injection achieves dual enhancement of flesh fiber volume and quality through bidirectional regulation-"promoting synthesis and inhibiting degradation":
- Promoting Protein Synthesis: Activates the mTOR pathway, increases ribosomal number, enhances translation efficiency, and specifically upregulates the expression of contractile and structural proteins.
- Inhibiting Protein Degradation: Downregulates key enzymes in the ubiquitin-proteasome and autophagy pathways, reducing abnormal flesh protein breakdown.
Most growth factors can only unidirectionally promote protein synthesis and cannot inhibit degradation, making their hypertrophic effects unstable and susceptible to internal metabolic environments. MGF's bidirectional regulatory model can consistently maintain a net anabolic advantage even in complex metabolic conditions (e.g., post-exercise, mild inflammation), resulting in more stable and significant flesh fiber hypertrophy. Animal studies show that local MGF intervention can increase skeletal flesh weight by 15%–25% and enhance maximal muscle contraction force by 20%–30%.
MGF-Induced Remodeling and Muscle Strength Enhancement
Under MGF influence, the hypertrophic effect is more pronounced in type II fast-twitch fibers (responsible for explosive power and absolute strength).
This leads to increased cross-sectional area, tighter fascicle arrangement, improved mechanical transmission efficiency, enhanced explosive power and endurance, and greater resistance to fatigue. These effects perfectly align with the core objectives in sports science: "efficient flesh building and enhanced athletic performance," which is also the primary reason for its prominence in the field of sports research.
FAQ
- Do you feel HGH immediately?
Some people feel an almost immediate improvement in the way they feel following an HGH peptide therapy session. For many others, it may take at least a few weeks to notice the desired results. Usually, you should feel improved physiological effects throughout the body within a few weeks.
- Can you feel TRT the first day?
For those who are just now receiving testosterone injections, they should be able to see small improvements within the first 3-4 days. Men will be able to sleep better and have more energy in the morning, and throughout the day. They may even feel a tad bit stronger if they hit the gym within the first week!
- Do you feel HGH immediately?
Some people feel an almost immediate improvement in the way they feel following an HGH peptide therapy session. For many others, it may take at least a few weeks to notice the desired results. Usually, you should feel improved physiological effects throughout the body within a few weeks.
- Can you feel TRT the first day?
For those who are just now receiving testosterone injections, they should be able to see small improvements within the first 3-4 days. Men will be able to sleep better and have more energy in the morning, and throughout the day. They may even feel a tad bit stronger if they hit the gym within the first week!
Hot Tags: mgf injection, China mgf injection manufacturers, suppliers, Tirzepatide Oral Drops, hgh fragment 176 191 peptide, Semaglutide Gummies, AOD 9604 Powder, AOD 9604 Injection, ghrp 6 tablets
